– IRELAND, Tralee – Kerry Group plc (LON: KYGA | OTC: KRYAY) today announced the appointments of Professor Catherine Godson and Dr. Genevieve Berger (MD, PhD) to its Board as Non-Executive Directors effective from 1 November 2023.
“We welcome Catherine’s appointment to the Board, and we look forward to leveraging her extensive biomedical research and biotechnology knowledge as the Group advances its positioning in the nutrition sector, particularly in the area of human health and emerging technologies”, said Board Chairman, Tom Moran. “We are delighted that Genevieve will be joining our Board. Genevieve brings with her expertise in the areas of human health, nutrition and ingredients which will support Kerry in its future development”.
About Professor Catherine Godson
Prof. Godson has an international reputation in scientific research gained during a long and successful academic career in the US, Switzerland, and at University College Dublin, during which time she held a number of senior management roles including VP of Innovation. She is currently the Director of the Diabetes Complications Research Centre at the UCD Conway Institute and UCD School of Medicine. Prof. Godson has a broad knowledge of human health and is a global expert on diabetes and cardiovascular and kidney diseases.
Prof. Godson is the Associate Dean of Research and Innovation at UCD School of Medicine and currently serves on the Irish Research Council and as a Trustee of Barts Charity, London.
About Dr. Genevieve Berger
Dr. Berger is a highly accomplished global science leader having served as Director General of one of the world’s largest research organizations the Centre National de la Recherche Scientifique, and who during her executive career held roles as the Chief Science Officer at Firmenich International SA as well as Chief Research & Development Officer and CSO at Unilever plc.
Dr Berger holds three doctorates, in addition to being a medical doctor, she holds a PhD in Physics and one in Human Biology.
Dr. Berger is a non-executive director of Dassault Systèmes SE and previously served on the Boards of Air Liquide SA, Astra Zeneca plc, and Smith & Nephew plc.
SOURCE: https://www.kerrygroup.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.